Published in J Gynecol Oncol on July 01, 2017
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol (1999) 40.46
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer (2014) 40.30
The fundamental role of epigenetic events in cancer. Nat Rev Genet (2002) 30.05
DNA methylation profiling of human chromosomes 6, 20 and 22. Nat Genet (2006) 18.08
The power and the promise of DNA methylation markers. Nat Rev Cancer (2003) 9.32
Epigenetics in cancer. Carcinogenesis (2009) 7.49
De novo methylation and expression of retroviral genomes during mouse embryogenesis. Nature (1982) 4.42
Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine (2008) 4.31
DNA methylation profiling in the clinic: applications and challenges. Nat Rev Genet (2012) 3.33
Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. CMAJ (2001) 2.56
Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. J Clin Microbiol (2006) 1.79
Regulation of DNA methyltransferase 1 by the pRb/E2F1 pathway. Cancer Res (2005) 1.53
Dysregulation of p53/Sp1 control leads to DNA methyltransferase-1 overexpression in lung cancer. Cancer Res (2010) 1.52
Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability. Genome Res (2013) 1.47
Identification of novel DNA methylation markers in cervical cancer. Int J Cancer (2008) 1.42
Methylation of human papillomavirus type 16 genome and risk of cervical precancer in a Costa Rican population. J Natl Cancer Inst (2012) 1.40
Methylation of HPV18, HPV31, and HPV45 genomes and cervical intraepithelial neoplasia grade 3. J Natl Cancer Inst (2012) 1.38
A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patients. Int J Cancer (2012) 1.28
Mechanisms of human papillomavirus E2-mediated repression of viral oncogene expression and cervical cancer cell growth inhibition. J Virol (2000) 1.27
DNA binding sites for putative methylation boundaries in the unmethylated region of the BRCA1 promoter. Int J Cancer (2004) 1.25
Integrated human papillomavirus types 52 and 58 are infrequently found in cervical cancer, and high viral loads predict risk of cervical cancer. Gynecol Oncol (2005) 1.17
Epigenetic alterations in preneoplastic and neoplastic lesions of the cervix. Clin Epigenetics (2012) 1.06
HPV-16 E6 upregulation of DNMT1 through repression of tumor suppressor p53. Oncol Rep (2010) 1.05
Immune responses against human papillomavirus (HPV) infection and evasion of host defense in cervical cancer. J Infect Chemother (2012) 1.00
Evidence that methylation of hepatitis B virus covalently closed circular DNA in liver tissues of patients with chronic hepatitis B modulates HBV replication. J Med Virol (2009) 1.00
Methylomic analysis identifies frequent DNA methylation of zinc finger protein 582 (ZNF582) in cervical neoplasms. PLoS One (2012) 0.99
Lytic induction and apoptosis of Epstein-Barr virus-associated gastric cancer cell line with epigenetic modifiers and ganciclovir. Cancer Lett (2006) 0.99
PAX1/SOX1 DNA methylation and cervical neoplasia detection: a Taiwanese Gynecologic Oncology Group (TGOG) study. Cancer Med (2014) 0.92
SEPT9: A Specific Circulating Biomarker for Colorectal Cancer. Adv Clin Chem (2015) 0.91
Human Papillomavirus 16, 18, 31 and 45 viral load, integration and methylation status stratified by cervical disease stage. BMC Cancer (2014) 0.89
Methylation of viral and host genes and severity of cervical lesions associated with human papillomavirus type 16. Int J Cancer (2014) 0.88
Patterns of cellular and HPV 16 methylation as biomarkers for cervical neoplasia. J Virol Methods (2012) 0.85
A comparison of methylation levels in HPV18, HPV31 and HPV33 genomes reveals similar associations with cervical precancers. J Clin Virol (2014) 0.85
Global methylation silencing of clustered proto-cadherin genes in cervical cancer: serving as diagnostic markers comparable to HPV. Cancer Med (2014) 0.83
Comparison of HPV genotyping and methylated ZNF582 as triage for women with equivocal liquid-based cytology results. Clin Epigenetics (2015) 0.83
Triage of high-risk human papillomavirus-positive women by methylated POU4F3. Clin Epigenetics (2015) 0.82
PAX1 methylation as an auxiliary biomarker for cervical cancer screening: a meta-analysis. Cancer Epidemiol (2015) 0.79
Increased methylation of Human Papillomavirus type 16 DNA correlates with viral integration in Vulval Intraepithelial Neoplasia. J Clin Virol (2014) 0.78